Momentum Builds Unevenly in Global Cannabis Reform — July 2025 Brief

This month’s brief captures a pivotal moment in the global cannabis sector, as reform momentum continues but faces intensifying regulatory headwinds. Governments are tightening oversight on prescribing and distribution — with telemedicine under the spotlight in Germany and Australia — as markets adapt to shifting access models and research adds fresh weight to the public […]

From Bans to Breakthroughs: Markets Evolve Amid Legal and Market Shifts — June 2025 Brief

Hi , welcome to the Cannamonitor brief. This month, we track the global cannabis sector’s steady evolution, with regulators tightening control, businesses innovating amid rising demand, and new research underscoring cannabis’ potential role in public health.   We highlight Germany’s regulatory clampdown on telemedicine and record medical imports, Poland’s rebound through hybrid clinics, and Australia’s prescription […]

Green Horizons: Mergers, Acquisitions & Milestones — December 2024 Brief

The global cannabis market is seeing notable developments, with the U.S. reaching a record $9.7 billion in tax revenue, Canada and Australia see major consolidation, Germany approves scientific pilot projects, Countries like Brazil, the UK, Israel, the Netherlands, and Poland are navigating market challenges and regulatory changes, while Morocco faces oversupply issues despite production growth.

Navigating Shifting Tides in the Global Market — November 2024 Brief

Welcome to November’s cannabis brief. This month, we highlight growth in certain U.S. markets amid shifting user demographics, and the expanding cannabis sectors in Australia, Germany, Brazil, and other jurisdictions. We also cover the internal struggle over tariffs in Israel, the agreement to make the Danish medical cannabis scheme permanent, favourable court decisions in Brazil, […]

Licensed Sales Struggle Against Illicit Market – October 2024 Brief

Welcome to October’s cannabis brief. This month we discuss how global jurisdictions struggle to curb the illicit market, the failure of Florida’s push for legalisation, and regulatory developments in Germany amid political turmoil. As always, we hope you gain valuable insights from our curated collection of global news and industry trends. Key figures from the […]

Global Shifts, Policy Debates and Market Dynamics — September 2024 Brief

September Cannabis News

Welcome to September’s cannabis brief. As always, we hope you gain valuable insights from our curated collection of global news and industry trends. This month saw significant developments in the global cannabis market. Germany passed a new hemp liberalization law while facing challenges with cannabis club licensing. In the U.S., the presidential race has spotlighted […]

Building Momentum, Navigating Regulatory Blocks — August 2024 Brief

Welcome to August’s cannabis brief, as always we hope you gain valuable insights from our curated collection of global news and industry trends. In August, we explore record sales by German medical cannabis operators, despite telemedicine concerns. The US presidential race is heating up, with candidates vying for the support of cannabis advocates. Meanwhile, Australia’s […]

Reaping the Rewards of Regulatory Change — July 2024 Brief

news in cannabis july 2024

Welcome to July’s cannabis brief, marking a full year of delivering monthly insights to our community of industry leaders! It’s an honour to provide intelligence that supports your strategic decisions across global markets. We hope the Brief continues to be a valuable resource for achieving your goals, and we welcome your feedback through our engagement form. […]

International Market Activity Heats Up with Summer — June 2024 Brief

We are delighted to welcome you to June’s cannabis brief. As always, we expect that you can derive valuable insights from our compilation of global news.   June has seen an explosion of activity in markets like Germany and the UK, as companies hurry to close agreements ahead of Summer. Consolidation in mature US states […]